MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) AND VENOUS THROMBOEMBOLISM (VTE) ACROSS UPADACITINIB CLINICAL TRIAL PROGRAMS IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Mysler, Eduardo [1 ]
Charles-Schoeman, Christina [2 ]
Choy, Ernest [3 ]
McInnes, Iain [4 ]
Nash, Peter [5 ]
Yamaoka, Kunihiro [6 ]
Lippe, Ralph [7 ]
Khan, Nasser [8 ]
Shmagel, Anna [8 ]
Palac, Hannah [8 ]
Suboticki, Jessica [8 ]
Curtis, Jeffrey [9 ]
机构：
[1] OMI Med Res Org, Buenos Aires, DF, Argentina
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] Cardiff Univ, Div Infect & Immun, Cardiff, Wales
[4] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland
[5] Griffith Univ, Brisbane, Qld, Australia
[6] Kitasato Univ, Sch Med, Sagamihara, Kanagawa, Japan
[7] AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany
[8] AbbVie, N Chicago, IL USA
[9] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PANLAR2023
引用
收藏
页码：S75 / S76
页数：2
相关论文
共 50 条
  • [1] MACE AND VTE ACROSS UPADACITINIB CLINICAL TRIAL PROGRAMS IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Charles-Schoeman, Christina
    Choy, Ernest
    McInnes, Iain B.
    Mysler, Eduardo
    Nash, Peter
    Yamaoka, Kunihiro
    Lippe, Ralph
    Khan, Nasser
    Palac, Hannah
    Suboticki, Jessica
    Curtis, Jeffrey
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 43 - 44
  • [2] MACE and VTE Across Upadacitinib Clinical Trial Programs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Charles-Schoeman, Christina
    Choy, Ernest
    McInnes, Iain B.
    Mysler, Eduardo
    Nash, Peter
    Yamaoka, Kunihiro
    Lippe, Ralph
    Khan, Nasser
    Shmagel, Anna K.
    Palac, Hannah
    Suboticki, Jessica
    Curtis, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1016 - 1019
  • [3] MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
    Charles-Schoeman, Christina
    Choy, Ernest
    McInnes, Iain B.
    Mysler, Eduardo
    Nash, Peter
    Yamaoka, Kunihiro
    Lippe, Ralph
    Khan, Nasser
    Shmagel, Anna K.
    Palac, Hannah
    Suboticki, Jessica
    Curtis, Jeffrey R.
    RMD OPEN, 2023, 9 (04):
  • [4] MALIGNANCY IN THE UPADACITINIB CLINICAL TRIAL PROGRAMS FOR RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Rubbert-Roth, Andrea
    Kakehasi, Adriana
    Takeuchi, Tsutomu
    Schmalzing, Marc
    Palac, Hannah
    Liu, Jianzhong
    Anyanwu, Samuel
    Lippe, Ralph
    Nash, Peter
    Curtis, Jeffrey
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 44 - 44
  • [5] Malignancy in the Upadacitinib Clinical Trial Programs for Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Rubbert-Roth, Andrea
    Kakehasi, Adriana
    Takeuchi, Tsutomu
    Schmalzing, Marc
    Palac, Hannah
    Liu, Jianzhong
    Anyanwu, Samuel
    Lippe, Ralph
    Curtis, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 562 - 564
  • [6] Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis
    Rubbert-Roth, Andrea
    Kakehasi, Adriana M.
    Takeuchi, Tsutomu
    Schmalzing, Marc
    Palac, Hannah
    Coombs, Derek
    Liu, Jianzhong
    Anyanwu, Samuel I.
    Lippe, Ralph
    Curtis, Jeffrey R.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (01) : 97 - 112
  • [7] PREDICTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS
    Semb, A. G.
    Kvien, T. K.
    Fayyad, R.
    DeMicco, D.
    Pedersen, T. R.
    LaRosa, J. C.
    Betteridge, J.
    Holme, I.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 165 - 165
  • [8] Rates of cardiovascular events in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis treated with etanercept or placebo in clinical trials.
    Bathon, J.
    Fleischmann, R.
    Peloso, P.
    Chon, Y.
    Hooper, M.
    Lin, S-L
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S188 - S188
  • [9] Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis
    Andrea Rubbert-Roth
    Adriana M. Kakehasi
    Tsutomu Takeuchi
    Marc Schmalzing
    Hannah Palac
    Derek Coombs
    Jianzhong Liu
    Samuel I. Anyanwu
    Ralph Lippe
    Jeffrey R. Curtis
    Rheumatology and Therapy, 2024, 11 : 97 - 112
  • [10] LONG-TERM SAFETY PROFILE OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS
    Nash, Peter
    Burmester, Gerd R.
    Cohen, Stanley B.
    Winthrop, Kevin
    Rubbert-Roth, Andrea
    Deodhar, Atul
    Elkayam, Ori
    Mysler, Eduardo
    Tanaka, Yoshiya
    Liu, Jianzhong
    Lacerda, Ana P.
    Pierre-Louis, Bosny J.
    Shaw, Tim
    Mease, Philip J.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 27 - 27
12345